HK65293A - Sucralfate preparations for application on esophagus mucosa - Google Patents

Sucralfate preparations for application on esophagus mucosa Download PDF

Info

Publication number
HK65293A
HK65293A HK652/93A HK65293A HK65293A HK 65293 A HK65293 A HK 65293A HK 652/93 A HK652/93 A HK 652/93A HK 65293 A HK65293 A HK 65293A HK 65293 A HK65293 A HK 65293A
Authority
HK
Hong Kong
Prior art keywords
sucralfate
suspension
esophagitis
water
preparation
Prior art date
Application number
HK652/93A
Other languages
German (de)
English (en)
Inventor
Kouji Ishihara
Toshichika Ogasawara
Kazuo Igusa
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of HK65293A publication Critical patent/HK65293A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)

Claims (2)

  1. Procédé pour la production d'un préparation à base de sucralfate sous la forme d'une suspension qui comprend la suspension du sucralfate dans une solution ou suspension aqueuse d'une ou plusieurs substances cellulosiques solubles dans l'eau ou insolubles dans l'eau comme agent de mise en suspension ou agent épaississant, caractérisée en ce que l'agent de mise en suspension ou agent épaississant cellulosique comprend au moins l'une d'entre la cellulose cristalline, l'hydroxyéthylcellulose et l'hydroxypropylméthylcellulose qui est ajoutée en une quantité telle que la suspension ait une viscosité de 1000 à 5000 mPas (centipoises) à 20°C.
  2. Procédé pour la production d'un préparation à base de sucralfate suivant la revendication l, à utiliser pour le traitement des inflammations de la muqueuse de l'oesophage.
HK652/93A 1986-05-16 1993-07-08 Sucralfate preparations for application on esophagus mucosa HK65293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11068686 1986-05-16

Publications (1)

Publication Number Publication Date
HK65293A true HK65293A (en) 1993-07-16

Family

ID=14541876

Family Applications (1)

Application Number Title Priority Date Filing Date
HK652/93A HK65293A (en) 1986-05-16 1993-07-08 Sucralfate preparations for application on esophagus mucosa

Country Status (14)

Country Link
EP (1) EP0245855B1 (fr)
JP (1) JP2583054B2 (fr)
KR (1) KR950005870B1 (fr)
AT (1) ATE84218T1 (fr)
AU (1) AU594765B2 (fr)
CA (1) CA1307465C (fr)
DE (1) DE3783390T2 (fr)
DK (1) DK164199C (fr)
ES (1) ES2053465T3 (fr)
FI (1) FI91598C (fr)
HK (1) HK65293A (fr)
NO (1) NO175516C (fr)
SG (1) SG64593G (fr)
ZA (1) ZA873496B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916880A (en) * 1987-12-21 1999-06-29 Bukh Meditec A/S Reduction of skin wrinkling using sulphated sugars
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5709873A (en) * 1988-02-26 1998-01-20 Niels Bukh A/S Method of treating conditions of teeth and their supporting tissue
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
JP2735559B2 (ja) * 1988-03-02 1998-04-02 中外製薬株式会社 懸濁液
US4975281A (en) * 1989-01-30 1990-12-04 E. R. Squibb & Sons, Inc. Anti-ulcer composition
US5618798A (en) * 1989-04-20 1997-04-08 Bar-Shalom; Daniel Use of sucralfate to treat baldness
IL95642A0 (en) * 1989-09-15 1991-06-30 Pehrom Pharmaceutical Corp Topical preparations for treatment of ulcers and other lesions
ATE209498T1 (de) * 1990-08-31 2001-12-15 Chugai Pharmaceutical Co Ltd Herstellung einer vorratslösung von in wasser suspendiertem sucralfat
FI924470A0 (fi) * 1992-10-05 1992-10-05 Orion Yhtymae Oy Sukralfatpreparat
IT1264546B1 (it) * 1993-07-30 1996-10-02 Lisapharma Spa Composizione farmaceutica ad attivita' antiacida in forma di sospensione a base di gel di sucralfato
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
US6319513B1 (en) 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
AU2001270304A1 (en) 2000-07-07 2002-01-21 The Administrators Of The Tulane Educational Fund Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
EP1339395A2 (fr) 2000-11-28 2003-09-03 Fmc Corporation Composition d'enrobage comestible en alginate de propylene glycol
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US10716802B2 (en) 2013-03-15 2020-07-21 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
JP6365235B2 (ja) 2014-10-28 2018-08-01 ライオン株式会社 液状組成物
WO2017053970A1 (fr) 2015-09-24 2017-03-30 The Brigham And Women's Hospital, Inc. Compositions mucoadhésives activées par l'eau pour réduire l'absorption intestinale de nutriments
JP2017178881A (ja) * 2016-03-31 2017-10-05 小林製薬株式会社 経口組成物
KR101837104B1 (ko) * 2017-04-14 2018-03-09 한국프라임제약주식회사 수크랄페이트 합성 방법 및 이에 의한 수크랄페이트
EP3941479A1 (fr) * 2019-03-20 2022-01-26 Reponex Pharmaceuticals A/S Ciblage d'agents biologiques sur des défauts muqueux du tractus gastro-intestinal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432489A (en) * 1965-11-05 1969-03-11 Chugai Pharmaceutical Co Ltd Disaccharide polysulfate aluminium compound and method
DE3315800A1 (de) * 1983-04-30 1984-10-31 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur herstellung eines granulats
CA1218601A (fr) * 1983-09-02 1987-03-03 Angel B. Casillan Suspension de sucralfate
DE3430809A1 (de) * 1984-08-22 1986-03-06 Merck Patent Gmbh, 6100 Darmstadt Sucralfat-suspension

Also Published As

Publication number Publication date
EP0245855A3 (en) 1988-06-08
AU594765B2 (en) 1990-03-15
ZA873496B (en) 1987-11-09
FI91598C (fi) 1994-07-25
EP0245855A2 (fr) 1987-11-19
DE3783390D1 (de) 1993-02-18
JP2583054B2 (ja) 1997-02-19
SG64593G (en) 1993-08-06
FI91598B (fi) 1994-04-15
NO872002D0 (no) 1987-05-14
JPS63107934A (ja) 1988-05-12
DE3783390T2 (de) 1993-05-06
EP0245855B1 (fr) 1993-01-07
DK243587D0 (da) 1987-05-13
NO175516C (no) 1994-10-26
ATE84218T1 (de) 1993-01-15
DK164199B (da) 1992-05-25
NO872002L (no) 1987-11-17
ES2053465T3 (es) 1994-08-01
DK164199C (da) 1992-10-19
DK243587A (da) 1987-11-17
KR950005870B1 (ko) 1995-06-02
FI872169L (fi) 1987-11-17
FI872169A0 (fi) 1987-05-15
KR890001515A (ko) 1989-03-27
AU7279587A (en) 1987-11-19
NO175516B (no) 1994-07-18
CA1307465C (fr) 1992-09-15

Similar Documents

Publication Publication Date Title
EP0245855B1 (fr) Préparations à base de sucralfate destinées à l'application sur la muqueuse de l'oesophage
JP7325853B2 (ja) 消化管粘膜用保護接着剤
DE68907679T2 (de) Sauerwiderstehender Fibroblast-Wachstumsfaktor, Zubereitung zur Behandlung von Magen-Darmweg-Geschwürkrankheiten.
JPH11503160A (ja) プロトンポンプ阻害剤を含有する医薬組成物
JP2002522491A (ja) リパーゼ阻害剤を含む製薬学的組成物
JP2001106632A (ja) 緩下剤の効力を高める方法及び組成物
EP4122483A1 (fr) Composition pharmaceutique orale
JPH10298110A (ja) 液体制酸薬製剤
JPS61205213A (ja) 製剤組成物
JPS60231617A (ja) 損傷消化管の治癒を促進する医薬組成物
DE3586281T2 (de) Antisaeurezusammensetzung.
US4693997A (en) Novel pharmaceutical composition
JP2004002320A (ja) 生体内で相転移する液状マトリックスおよび液状経口製剤
JP2002522392A (ja) 低下された消化管毒性を有するカンプトテシン誘導体の使用
JP2511577B2 (ja) アルギン酸プロピレングリコ―ルエステルからなる徐放性製剤
EP3610858A1 (fr) Composition liquide de suspension de smectite et son procédé de préparation
WO1998001112A1 (fr) Nouvelle utilisation d'une formulation d'hydrogel
JPS60231618A (ja) 胃腸潰瘍の治癒促進用製剤組成物
WO2003015807A1 (fr) Agents supprimant les effets indesirables et/ou stimulateurs de l'effet hypoglycemique destines aux derives de thiazolidine
JPH11116485A (ja) スクラルファート懸濁液製剤
EP0248740A2 (fr) Composition contenant un gel d'hydroxyde d'aluminium
JP2000256182A (ja) 抗菌製剤
RU2020931C1 (ru) Способ получения лекарственного средства для лечения язвенной болезни желудочно-кишечного тракта млекопитающих
CA2373166C (fr) Agent antiulcereux
WO2000040254A1 (fr) Composition pharmaceutique destinee a une administration par voie orale presentant une activite therapeutique sur des troubles gastro-intestinaux

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20070513